StockWatch
·
Pharmaceuticals
Quarterly Result29 May 2026, 04:20 pm

Brawn Biotech Audited Results for Quarter and Year Ended 31.03.2026

AI Summary

Brawn Biotech Ltd. announced the audited financial results for the quarter and year ended 31st March 2026. The Board of Directors approved the results in their meeting held on 29th May 2026. Revenue from operations for the year ended March 31, 2026, stood at ₹1,697.77 Lacs. The meeting commenced at 3:30 PM and concluded at 4:00 PM.

Key Highlights

  • Brawn Biotech's board approved audited financial results on May 29, 2026.
  • Revenue from operations for FY26 is ₹1,697.77 Lacs.
  • The audit committee reviewed the results.
  • Meeting of the board of directors commenced at 3:30 PM and concluded at 4:00 PM.